NAR Releases New Consumer-Focused Resources Ahead of Practice Changes in Settlement Agreement
July 30, 2024 17:25 ET
|
National Association of Realtors®
Chicago, July 30, 2024 (GLOBE NEWSWIRE) -- The National Association of REALTORS® (NAR) today published new resources to help guide consumers on the impact of the March 15th settlement agreement...
Farmers and Merchants Bancshares, Inc. Announces Adoption of Limited Duration Stockholder Rights Plan
July 30, 2024 17:00 ET
|
Farmers and Merchants Bancshares, Inc.
Board Acts to Protect the Interests of the Company and its Stockholders Following an Investor Group’s Filing of an “Interagency Notice of Change in Bank Control” with Regulators Stockholders Do...
Ceylon Graphite Delayed in Completion of Annual Filings
July 30, 2024 17:00 ET
|
Ceylon Graphite Corp.
Vancouver, BC, July 30, 2024 (GLOBE NEWSWIRE) -- Ceylon Graphite Corp. ("Ceylon" or the “Company”) (TSX-V: CYL) (OTC: CYLYF) (FSE: CCY) announces today that it will not be in a position to file its...
DHT Holdings, Inc. to announce second quarter 2024 results on Monday, August 12, 2024
July 30, 2024 16:15 ET
|
DHT Holdings, Inc.
HAMILTON, BERMUDA, July 30, 2024 - DHT Holdings, Inc. (NYSE: DHT or the “Company”) will release its second quarter 2024 results after market close on Monday, August 12, 2024. The Company will host a...
COMSTOCK RESOURCES, INC. REPORTS SECOND QUARTER 2024 FINANCIAL AND OPERATING RESULTS
July 30, 2024 16:15 ET
|
Comstock Resources, Inc.
FRISCO, TX, July 30, 2024 (GLOBE NEWSWIRE) -- Comstock Resources, Inc. ("Comstock" or the "Company") (NYSE: CRK) today reported financial and operating results for the quarter ended June 30, 2024. ...
Panbela to Host Second Quarter 2024 Earnings Conference Call on Aug 13, 2024
July 30, 2024 16:15 ET
|
Panbela Therapeutics, Inc.
MINNEAPOLIS, July 30, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with...
MacroGenics Provides Vobramitamab Duocarmazine Update
July 30, 2024 16:10 ET
|
MacroGenics, Inc.
Abstract of clinical data accepted for poster presentation at ESMO Congress 2024 in SeptemberESMO poster to include protocol-defined TAMARACK Phase 2 mCRPC study data, including pre-defined landmark...
MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration with Incyte
July 30, 2024 16:01 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, July 30, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative...
Xylo Technologies Announces Plan to Implement ADS Ratio Change
July 30, 2024 16:00 ET
|
Xylo Technologies Ltd.
Tel Aviv, Israel, July 30, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo” and the “Company”), a technology company engaged in advanced medical solutions, innovative internet...
Nokia Oyj: Omien osakkeiden takaisinosto 30.07.2024
July 30, 2024 15:30 ET
|
Nokia Oyj
Nokia OyjPörssitiedote30.07.2024 klo 22.30 Nokia Oyj: Omien osakkeiden takaisinosto 30.07.2024 Espoo – Nokia Oyj (LEI: 549300A0JPRWG1KI7U06) on 30.07.2024 hankkinut omia osakkeitaan (ISIN...